Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

DOI Web Site Web Site 11 Citations

Journal

  • The Lancet

    The Lancet 394 (10193), 131-138, 2019-07

    Elsevier BV

Citations (11)*help

See more

Report a problem

Back to top